Phase I/II study of S-1 combined with biweekly irinotecan chemotherapy in previously treated advanced non-small cell lung cancer

被引：0
|
作者：
Hiroki Goya
Hiroshi Kuraishi
Shigeru Koyama
Takashi Ichiyama
Fumiaki Yoshiike
Kazuya Hirai
Toshihiko Agatsuma
Kazunari Tateishi
Shintaro Kanda
Hiroshi Yamamoto
Keishi Kubo
Tomonobu Koizumi
机构：
[1] Nagano Red Cross Hospital,Respiratory Division
[2] Nagano Municipal Hospital,Respiratory Division
[3] Shinshu University School of Medicine,First Department of Internal Medicine
[4] Shinshu University Hospital School of Medicine,Division of Clinical Oncology, Comprehensive Cancer Center
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 70卷
关键词：
Chemo-refractory; Salvage chemotherapy; Second line; CTP-11;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：691 / 697
页数：6
相关论文
共 50 条
  • [21] Phase I/II trial of a biweekly combination of S-1 plus docetaxel in patients with previously treated non-small cell lung cancer (KRSG-0601)
    K Komiyama
    K Kobayashi
    S Minezaki
    F Kotajima
    A Sutani
    T Kasai
    K Mori
    E Hoshi
    N Takayanagi
    S Koyama
    K Eguchi
    M Nakayama
    K Kikuchi
    British Journal of Cancer, 2012, 107 : 1474 - 1480
  • [22] Phase II study of carboplatin combined with biweekly docetaxel for advanced non-small cell lung cancer
    Ishimoto, Osamu
    Sugawara, Shunichi
    Inoue, Akira
    Ishida, Takashi
    Munakata, Mitsuru
    Koinumaru, Sadahiro
    Hasegawa, Yukihiro
    Suzuki, Toshiro
    Miki, Hiroshi
    Saijo, Yasuo
    Nukiwa, Toshihiro
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (09) : 979 - 983
  • [23] Phase II study of S-1 monotherapy in patients with previously treated, advanced non-small-cell lung cancer
    M. Wada
    M. Yamamoto
    S. Ryuge
    Y. Nagashima
    N. Hayashi
    S. Maki
    S. Otani
    K. Katono
    A. Takakura
    T. Yanaihara
    S. Igawa
    M. Yokoba
    H. Mitsufuji
    M. Kubota
    M. Katagiri
    N. Masuda
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1005 - 1011
  • [24] Phase II study of S-1 monotherapy in patients with previously treated, advanced non-small-cell lung cancer
    Wada, M.
    Yamamoto, M.
    Ryuge, S.
    Nagashima, Y.
    Hayashi, N.
    Maki, S.
    Otani, S.
    Katono, K.
    Takakura, A.
    Yanaihara, T.
    Igawa, S.
    Yokoba, M.
    Mitsufuji, H.
    Kubota, M.
    Katagiri, M.
    Masuda, N.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (04) : 1005 - 1011
  • [25] A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancer
    Komiya, Takefumi
    Memmott, Regan M.
    Blumenthal, Gideon M.
    Bernstein, Wendy
    Ballas, Marc S.
    De Chowdhury, Roopa
    Chun, Guinevere
    Peer, Cody J.
    Figg, William D.
    Liewehr, David J.
    Steinberg, Seth M.
    Giaccone, Giuseppe
    Szabo, Eva
    Kawabata, Shigeru
    Tsurutani, Junji
    Rajan, Arun
    Dennis, Phillip A.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (03) : 247 - +
  • [26] Phase II study of irinotecan plus S-1 combination for previously untreated advanced non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group 0601
    Oizumi, S.
    Akie, K.
    Ogura, S.
    Shinagawa, N.
    Fukumoto, S.
    Harada, M.
    Kojima, T.
    Kinoshita, I.
    Dosaka-Akita, H.
    Isobe, H.
    Nishimura, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [27] A phase II study of irinotecan combined with S-1 in patients with advanced or recurrent cervical cancer previously treated with platinum based chemotherapy
    Mabuchi, Seiji
    Yokoi, Eriko
    Shimura, Kotaro
    Komura, Naoko
    Matsumoto, Yuri
    Sawada, Kenjiro
    Isobe, Aki
    Tsutsui, Tateki
    Kitada, Fuminori
    Kimura, Tadashi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (03) : 474 - 479
  • [28] Phase II study of docetaxel and S-1 combination therapy in patients with previously treated non-small cell lung cancer
    Atagi, S.
    Kawahara, M.
    Kubo, A.
    Kawaguchi, T.
    Yumine, K.
    Okishio, K.
    Tomizawa, Y.
    Komatsu, H.
    Fukai, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [29] Irinotecan and gemcitabine in patients with advanced non-small cell lung cancer, previously treated with cisplatin-based chemotherapy. A phase II study
    Pectasides, D
    Mylonakis, N
    Farmakis, D
    Nikolaou, M
    Koumpou, M
    Katselis, I
    Gaglia, A
    Kostopoulou, V
    Karabelis, A
    Kosmas, C
    ANTICANCER RESEARCH, 2003, 23 (5B) : 4205 - 4211
  • [30] Phase II Study of S-1 and Paclitaxel Combination Therapy in Patients with Previously Treated Non-Small Cell Lung Cancer
    Chihara, Yusuke
    Yoshimura, Akihiro
    Date, Koji
    Takemura, Yoshizumi
    Tamiya, Nobuyo
    Kohno, Yoshihito
    Imabayashi, Tatsuya
    Takeuchi, Mayumi
    Kaneko, Yoshiko
    Yamada, Tadaaki
    Ueda, Mikio
    Arimoto, Taichiro
    Uchino, Junji
    Iwasaki, Yoshinobu
    Takayama, Koichi
    ONCOLOGIST, 2019, 24 (08): : 1033 - +
12345